Latest Share Chat

REMOVE ADS

SLN.L Share News (SLN)

SLN.L Information

There is currently no data for SLN

REMOVE ADS

SLN.L News

Silence Therapeutics Chief Financial Officer David Ellam Resigns

LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday Chief Financial Officer David Ellam has resigned from the serious disease treatment f...

US Patent Board Rejects Alnylam's Claim Against Silence Therapeutics

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday the US Patent Trial & Appeal Board rejected Alnylam Pharmaceutics Inc's petition again...

Silence Therapeutics Files Interim Injunction Against Alnylam

LONDON (Alliance News) - Silence Therapeutics PLC said Wednesday it filed a cross-border interim injunction application to stop Alnylam Pharmaceutical...

Silence Therapeutics losses deepen as lead drugs near trials

(Sharecast News) - Biotechnology firm Silence Therapeutics shares fell on Tuesday after reporting a first half loss after tax of £8.7m, up 57%, due to...

Silence Therapeutics Interim Loss Widens As Research Costs Surge

LONDON (Alliance News) - Silence Therapeutics PLC said Tuesday that its loss for the first half of the financial year widened as research & developmen...

UK Earnings, Trading Statements Calendar - Next 7 Days

Wednesday 5 September Barratt DevelopmentsFull Year ResultsBreedon GroupHalf Year Year 6

Silence Therapeutics Executive Chair Jenkins Steps Down

LONDON (Alliance News) - Silence Therapeutics PLC said Monday that Executive Chair Annalisa Jenkins will be leaving her role with immediate effect aft...

Silence Therapeutics Appoints Dave Lemus As Non-Executive Director

LONDON (Alliance News) - Silence Therapeutics PLC said Thursday it appointed Dave Lemus to the board as non-executive director effective immediately.T...